SBC Medical Group Holdings Incorporated Increase (Decrease) in Accounts Payable, Trade
SBC Medical Group Holdings Incorporated (SBC) reported Increase (Decrease) in Accounts Payable, Trade of $6.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $4.11M.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $2.48M, a 23.20% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $125.13K, a 86.45% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $1.38M.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for fiscal 2025 was $2.68M.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for fiscal 2024 was -$9.59M, a 178.58% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated increase (decrease) in accounts payable, trade for fiscal 2023 was $12.20M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.59M 10-Q · filed 2026-08-13 | $6.72M derived: sum of 3 quarters · filed 2026-08-13 | $8.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.48M 10-Q · filed 2026-05-14 | $2.61M derived: sum of 2 quarters · filed 2026-05-14 | $3.99M derived: sum of 3 quarters · filed 2026-05-14 | $1.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $125.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.51M derived: sum of 2 quarters · filed 2026-03-27 | -$559.95K derived: sum of 3 quarters · filed 2026-08-13 | $2.68M 10-K · filed 2026-03-27 |
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$685.08K derived: sum of 2 quarters · filed 2026-08-13 | $2.55M 10-Q · filed 2025-11-14 | $3.47M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.17M 10-Q · filed 2026-08-13 | $2.09M derived: sum of 3 quarters · filed 2026-08-13 | $537.71K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.24M 10-Q · filed 2026-05-14 | $4.16M derived: sum of 2 quarters · filed 2026-05-14 | $2.61M derived: sum of 3 quarters · filed 2026-05-14 | $2.58M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $923.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$627.51K derived: sum of 2 quarters · filed 2026-03-27 | -$650.63K derived: sum of 3 quarters · filed 2026-03-27 | -$9.59M 10-K · filed 2026-03-27 |
| 2024-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.57M derived: sum of 2 quarters · filed 2025-11-14 | -$10.51M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$23.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$8.96M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$8.94M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $12.20M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |